CTI BioPharma (NASDAQ: CTIC) and Baxter International Inc. (NYSE: BAX) announced that data from the randomized Phase 3 PERSIST-1 trial evaluating the investigational agent pacritinib in patients with myelofibrosis will be highlighted in a late-breaking ...
In addition, veteran Prudential Alliance manager Bob Bax has been added to the company's ownership group. In 2013, Prudential Alliance sales in the St. Louis area reached $743.5 million, with 3,259 closed transactions, the Chesterfield-based company said.
In this study, we found that CtBP represses Bcl-2-associated X protein (Bax) transcription in glucose-rich media by binding to the E-box region of the Bax promoter. Glucose withdrawal leads to the dissociation of CtBP from the Bax promoter and significant ...
Nature · 9y
Baxter International Inc. (BAX) announced, for 2018, the company now expects sales growth of approximately 7 to 8 percent on a reported basis, approximately 5 percent on a constant currency basis and 4 to 5 percent on an operational basis. Baxter expects ...
RTTNews · 1mon
"The memory I have of my son, no one can ever take it from me." Defense attorney Arie Bax had asked Cooper for the minimum sentence of 30 years. Fourteenth Circuit Solicitor Duffie Stone argued Robinson had not earned leniency after spending his adult life ...
Baxter Intl Inc (NYSE:BAX) traded in a range yesterday that spanned from a low of $71.26 to a high of $72.42. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $72.37 on volume of 938,000 shares. Often times after ...
SmarTrend · 5mon
Baxter International Inc. (BAX) entered a global licensing agreement with Cell Therapeutics, Inc. (CTIC) to jointly develop and commercialize JAK2/FLT3 inhibitor pacritinib that fights against genetic mutations linked to myelofibrosis, leukemia and some ...
NEW YORK (CNNfn) - Market strategists reviewed stocks in sectors such as health care, Internet, and banking on Friday, recommending companies such as Baxter International. As the markets fell in midday trading, recent guests on CNNfn commented on the ...
CNN Money · 1mon
Veeva (VEEV) strengthens its position by providing the life sciences industry with a streamlined commercial database besides notable technological innovations.
It is growing at about 12-15 percent and trading at about 6 1/2 times earnings." The views presented here are solely those of the analysts quoted. They do not represent the opinions of CNNfn on whether to buy or sell shares of a particular stock.
CNN Money · 4y